Clinical trial
Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With…
NCT00416962 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00416962 |
|---|---|
| Title | Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine |
| Official title | An Open-Label, Multiple Dose, Randomized, Three-Period Crossover Study in Healthy Volunteers to Evaluate the Effect of co-Administration of Amantadine 100 mg BID and Oseltamivir 75 mg BID on the Pharmacokinetic Properties of Amantadine and Oseltamivir. |
| Lead sponsor | Novartis, Industry |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | amantadine hydrochloride, oseltamivir phosphate |
| Enrollment | 18 |
| Start date | Aug 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Dec 28, 2006 |
| Last update posted | Nov 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: